Tue Nov 12 07:24:45 UTC 2024: ## Three IPOs Open This Week: Investment Opportunities in Logistics, Pharma and IT
**Mumbai, India:** The Indian stock market is set to witness a flurry of Initial Public Offerings (IPOs) this week, offering investors a chance to participate in diverse sectors. Three companies – **Zinka Logistics Solutions Limited, Onyx Biotec Limited, and Mangal Compusolution Limited** – are launching their IPOs, catering to various investment appetites.
**Zinka Logistics Solutions Limited:** This digital platform for truck owners is launching a ₹1,115 crore IPO, opening on November 13th and closing on November 18th. The price band is set at ₹259-273 per share. The IPO comprises ₹550 crore of fresh issue and an Offer for Sale (OFS) of 2.06 crore shares. The company plans to utilize the proceeds for sales and marketing initiatives, investment in Blackbuck Finserv, product development, and general corporate purposes. Its Grey Market Premium (GMP) is currently at ₹24 per share.
**Onyx Biotec Limited:** This pharmaceutical company, listed in the SME segment, is looking to raise ₹29.34 crore through a book-built issue. The IPO opens on November 13th and closes on November 18th, with listing expected on the NSE SME index on November 21st. The price band is set at ₹58-61 per share, with a minimum investment of ₹1,22,000 for retail investors and ₹2,44,000 for High Net-worth Individuals (HNIs). Its GMP is currently at ₹5 per share.
**Mangal Compusolution Limited:** This IT hardware solutions provider, also in the SME segment, is launching its IPO on November 12th, closing on November 14th. The company aims to raise ₹16.23 crore and is expected to list on the BSE SME index on November 20th. The price band is set at ₹45 per share, with a minimum investment of ₹1,35,000 for retail investors and ₹2,70,000 for HNIs. Its GMP is currently at ₹3 per share.
Investors looking to diversify their portfolios can explore these IPOs, which represent various sectors like logistics, pharmaceuticals, and IT. However, it is crucial to conduct thorough research and consult with financial advisors before making any investment decisions.